Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck KGaA
Merck KGaA
German Merck, Pfizer get FDA priority review for cancer drug
Yahoo/Reuters
Tue, 11/29/16 - 09:55 am
Merck KGaA
Pfizer
FDA
Merkel cell carcinoma
skin cancer
avelumab
Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales
TheStreet.com
Tue, 11/15/16 - 09:33 am
Merck KGaA
earnings
Did Merck KGaA’s aging atacicept just fail a PhIIb lupus trial? Well, yes, but…
Endpoints
Mon, 11/14/16 - 11:16 am
Merck KGaA
atacicept
lupus
clinical trials
Merck KGaA, Pfizer and Transgene team up on cancer vaccine
BioPharma Dive
Wed, 10/12/16 - 11:18 pm
Merck KGaA
Pfizer
Transgene
vaccines
TG40001
HPV head and neck cancer
Merck KGaA Publishes First International Curiosity Study
Yahoo
Wed, 10/12/16 - 11:30 am
Merck KGaA
curiosity
pharma employees
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Motley Fool
Tue, 09/27/16 - 10:51 am
Pfizer
Medivation
Xtandi
avelumab
Merck KGaA
Ibrance
Pfizer, Germany's Merck begin large ovarian cancer trial
Yahoo/Reuters
Thu, 07/7/16 - 09:25 am
Pfizer
Merck KGaA
avelumab
ovarian cancer
Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results
BioPharma Dive
Fri, 05/20/16 - 10:28 am
Merck KGaA
Pfizer
PD-L1
Merkel cell carcinoma
The Two Mercks Are Locking Horns in a Naming Trademark Spat
Fortune
Mon, 04/18/16 - 06:44 pm
Merck KGaA
Merck
trademark
Merck KGaA says consumer health saw 'nice' growth in 2015
Yahoo/Reuters
Tue, 02/23/16 - 05:51 pm
Merck KGaA
consumer health
It's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown
Fierce Pharma
Sat, 01/16/16 - 11:39 am
Merck
Merck KGaA
social media
Pfizer, Merck KGaA launch two more PhIII trials for avelumab
Fierce Biotech
Tue, 12/22/15 - 10:00 pm
Pfizer
Merck KGaA
avelumab
ovarian cancer
anti-PD-L1
Merck KGaA, Threshold drug fails in late-stage cancer trials
Yahoo/Reuters
Mon, 12/7/15 - 10:21 am
Merck KGaA
Threshold Pharmaceuticals
evofosfamide
The Path Is Clear for a New Immunotherapy Entrant
Motley Fool
Tue, 12/1/15 - 02:16 pm
immunotherapy
avelumab
Merck KGaA
Pfizer
Merck KGaA beats in Q3 despite competition to MS injectable Rebif
Fierce Pharma
Fri, 11/13/15 - 10:00 am
Merck KGaA
earnings
Merck KGaA, Pfizer widen development of cancer immunology drug
Yahoo/Reuters
Wed, 11/4/15 - 02:05 pm
Merck KGaA
Pfizer
cancer immunotherapy
avelumab
Merck KGaA hopes to spiff up its image with new logo, fewer names
Fierce Pharma Marketing
Wed, 10/14/15 - 02:16 pm
Merck KGaA
Merck KGaA bets on cancer drugs to revitalize German firm
Yahoo/Reuters
Mon, 10/12/15 - 09:16 am
Merck KGaA
cancer
Merck Serono
Rebif
Erbitux
Merck KGaA hustling a promising anti-malaria drug into human studies
Fierce Biotech
Thu, 06/18/15 - 10:26 am
Merck KGaA
malaria
DDD107498
Merck KGaA sees immunotherapy drug holding its own in cancer race
Yahoo/Reuters
Tue, 06/2/15 - 09:06 am
Merck KGaA
avelumab
Pfizer
ASCO
cancer immunotherapy
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »